Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06191562

Posterior vs. Anterior Tympanostomy Tube Placement

The goal of this randomized clinical trial is to compare the results of ear tube placement in two different parts of the ear drum. The ear drum can be divided into four parts (called quadrants). Ear tubes are usually placed in one section of the ear drum, called the anterior-inferior quadrant. However, tubes can also be placed in another section, called the posterior-inferior quadrant. Ear tubes usually fall out of the ear drum on their own. In most patients, the hole in the ear drum where the tube used to be closes on its own. Sometimes (in about 2% of patients), the hole does not close on its own and might need surgery. We want to study ear tube placement in the posterior-inferior quadrant because surgery to repair a hole in the eardrum is easier in this location.

For this study, children will receive an ear tube in the usual location (anterior-inferior quadrant) in one ear and the new location (posterior-inferior quadrant) in the other ear. Researchers will determine which ear has the new location using random assignment (like flipping a coin). Researchers will collect information about hearing tests, whether there is ear drainage (otorrhea), if the tube is blocked (occluded), and how the ear drum looks for up to 37 months after tube placement. Participants will answer study questions at 2-12 weeks and 6, 12, 18, 24, 30, and 36 months after surgery. These questions will ask about whether tubes have fallen out of the ear drum, whether there is a hole in the ear drum, whether there has been drainage from the ear or other ear symptoms, and whether there have been any visits to the doctor for ear problems.

Researchers will use this information to compare ears with anterior-inferior tube placement and ears with posterior-inferior tube placement to see if there are differences in common complications following tube placement.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

6 month–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

Loading trial locations.

About this study

The tympanic membrane can be divided into quadrants: posterior superior, anterior superior, posterior inferior, and anterior inferior. Traditional training dictates that tympanostomy tubes should be placed in the anterior-inferior quadrant, with the thought that this would lead to longer indwelling time in the tympanic membrane, avoidance of damage to the ossicular chain, and prevention of hearing loss due to residual perforation over the round window following tympanostomy tube extrusion. However, more recent work has challenged these assumptions. Notably, there is a 2-16% risk of chronic perforation following tympanostomy tube extrusion, with a proposed annual incidence of more than 40,000 post-tympanostomy tube perforations in the United States each year. While perforations in the posterior tympanic membrane can often be repaired using transcanal approaches, anterior perforations are more likely to require more invasive postauricular or endoaural approaches or canalplasty. To our knowledge, there are no studies reporting outcomes following tympanostomy tube placement in the posterior-inferior quadrant. If this study demonstrates no difference in hearing, tube indwelling time, and sequelae following posterior-inferior placement compared with anterior-inferior, it would allow otolaryngologists greater flexibility to consider patient characteristics such as factors placing them at increased risk for perforation or anatomy of the auditory canal when selecting the section of tympanic membrane in which to place tubes.

Upon completion of screening, patients will be randomized using a random number generator in order to have an equal distribution of left and right ears with tympanostomy tubes placed in the anterior and posterior quadrants. Consented patients will receive an ear tube in the usual location (anterior-inferior) in one ear and a new location (posterior-inferior) in the other ear during surgery. Follow-up will include standard-of-care post-operative visits and may be completed at 2-12 weeks and 5-7 months. Clinicians will examine the child's ears and determine whether otorrhea and occlusion are present. During the visit, audiologists may conduct standard of care ear-specific pure tone average, air-bone gap, and sound field audiometry. At these follow-up visits, otolaryngology providers will complete a form describing the status of the tympanic membrane. This will add <1 minute to the visit. Caregivers will also complete a form asking about the status of their child's tympanostomy tubes and any ear problems their child has experienced since surgery. This will take <5 minutes to complete. Results of audiology testing will be collected from the electronic medical record. Additional follow-up will include administration of the caregiver questions via phone, mail, or REDCap email at 12, 18, 24, 30, and 36 months. If the child has other follow-up clinic visits prior to 37 months post-surgery, the provider form will be completed again during these visits. Further research activities will include viewing medical charts of the included subjects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages 6 months -14 years
  • Bilateral tympanostomy tube placement
  • First tympanostomy tubes placement
  • Indication for tympanostomy tube placement is otitis media

Exclusion criteria

  • Undergoing tympanostomy tube placement for indication other than otitis media
  • Receiving tubes other than Armstrong grommet.
  • Genetic disorder that impacts the craniofacial structure, immune system, or mucosal secretions such as Downs syndrome, Stickler syndrome, Treacher Collins syndrome, other genetic disorder associated with craniofacial anomalies, Severe Combined Immunodeficiency disorder, Cystic Fibrosis, or Primary Ciliary Dyskinesia
  • Patients with craniofacial abnormalities other than plagiocephaly or submucous cleft palate (SMCP)
  • Caregivers who cannot speak, read, or write in English proficiently
  • Prior or current otologic surgery other than tympanostomy tube placement
  • On systemic corticosteroids at the time of enrollment
  • Immunodeficiency (acquired or congenital)
  • Current retraction, cholesteatoma, or middle ear mass
  • Atresia
  • Sensorineural hearing loss
  • Known ossicular chain anomaly

Treatment and study plan

tympanostomy tube

Device

Participants will receive an ear tube in the usual location (anterior-inferior) in one ear and a new location (posterior-inferior) in the other ear during surgery.

Other names: Myringotomy with tubes; pressure equalization tubes; ventilation tubes

Primary outcomes

  1. Perforation

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Percentage of ears with persistent (>3 month) perforation of the tympanic membrane

Secondary outcomes

  1. Parent-reported otorrhea at 2-12 weeks

    Time frame: 2-12 weeks following tympanostomy tube placement

    Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0)

  2. Parent-reported otorrhea at 6 months

    Time frame: 6 months±30 days following tympanostomy tube placement

    Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0)

  3. Provider-observed tube occlusion at 2-12 weeks

    Time frame: 2-12 weeks following tympanostomy tube placement

    Percentage of ears with tubes occluded

  4. Provider-observed tube occlusion at 6 months

    Time frame: 6 months±30 days following tympanostomy tube placement

    Percentage of ears with tubes occluded

  5. Provider-observed tympanostomy tubes in place and patent at 2-12 weeks

    Time frame: 2-12 weeks following tympanostomy tube placement

    Percentage of ears with tympanostomy tubes in place and patent

  6. Provider-observed tympanostomy tubes in place and patent at 6 months

    Time frame: 6 months±30 days following tympanostomy tube placement

    Percentage of ears with tympanostomy tubes in place and patent

  7. Retained tubes requiring surgical intervention

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Percentage of ears requiring surgical tympanostomy tube removal

  8. Perforation requiring surgical intervention

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Percentage of ears with surgical repair of perforation

  9. Atrophy or retraction at tube site

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Percentage of ears with atrophy or retraction at tube site

  10. Cholesteatoma

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Percentage of ears with cholesteatoma

  11. Hearing loss

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Percentage of ears with pure tone average >20 dB or absent otoacoustic emissions

  12. Tube indwelling time before extrusion

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Months from tympanostomy tube placement to extrusion estimated from parent-report and provider observations

  13. Ability to see through lumen and assess tube patency at 2-12 weeks

    Time frame: 2-12 weeks following tympanostomy tube placement

    Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency

  14. Ability to see through lumen and assess tube patency at 6 months

    Time frame: 6 months±30 days following tympanostomy tube placement

    Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency

Other outcomes

  1. Parent-reported otorrhea at 12 months

    Time frame: 12 months±30 days following tympanostomy tube placement

    Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0)

  2. Parent-reported otorrhea at 18 months

    Time frame: 18 months±30 days following tympanostomy tube placement

    Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0)

  3. Parent-reported otorrhea at 24 months

    Time frame: 24 months±30 days following tympanostomy tube placement

    Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0)

  4. Parent-reported otorrhea at 30 months

    Time frame: 30 months±30 days following tympanostomy tube placement

    Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0)

  5. Parent-reported otorrhea at 36 months

    Time frame: 36 months±30 days following tympanostomy tube placement

    Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0)

  6. Parent-reported blockage of tube lumen at 2-12 weeks

    Time frame: 2-12 weeks following tympanostomy tube placement

    Percentage of ears clogged/blocked

  7. Parent-reported blockage of tube lumen at 6 months

    Time frame: 6 months±30 days following tympanostomy tube placement

    Percentage of ears clogged/blocked

  8. Parent-reported blockage of tube lumen at 12 months

    Time frame: 12 months±30 days following tympanostomy tube placement

    Percentage of ears clogged/blocked

  9. Parent-reported blockage of tube lumen at 18 months

    Time frame: 18 months±30 days following tympanostomy tube placement

    Percentage of ears clogged/blocked

  10. Parent-reported blockage of tube lumen at 24 months

    Time frame: 24 months±30 days following tympanostomy tube placement

    Percentage of ears clogged/blocked

  11. Parent-reported blockage of tube lumen at 30 months

    Time frame: 30 months±30 days following tympanostomy tube placement

    Percentage of ears clogged/blocked

  12. Parent-reported blockage of tube lumen at 36 months

    Time frame: 36 months±30 days following tympanostomy tube placement

    Percentage of ears clogged/blocked

  13. Provider-observed otorrhea at 2-12 weeks

    Time frame: 2-12 weeks following tympanostomy tube placement

    Percentage of ears with otorrhea observed by provider

  14. Provider-observed otorrhea at 6 months

    Time frame: 6 months±30 days following tympanostomy tube placement

    Percentage of ears with otorrhea observed by provider

  15. Provider-observed otorrhea at 12 months

    Time frame: 12 months±30 days following tympanostomy tube placement

    Percentage of ears with otorrhea observed by provider

  16. Provider-observed otorrhea at 18 months

    Time frame: 18 months±30 days following tympanostomy tube placement

    Percentage of ears with otorrhea observed by provider

  17. Provider-observed otorrhea at 24 months

    Time frame: 24 months±30 days following tympanostomy tube placement

    Percentage of ears with otorrhea observed by provider

  18. Provider-observed otorrhea at 30 months

    Time frame: 30 months±30 days following tympanostomy tube placement

    Percentage of ears with otorrhea observed by provider

  19. Provider-observed otorrhea at 36 months

    Time frame: 36 months±30 days following tympanostomy tube placement

    Percentage of ears with otorrhea observed by provider

  20. Provider-observed tube occlusion at 12 months

    Time frame: 12 months±30 days following tympanostomy tube placement

    Percentage of ears with tubes occluded

  21. Provider-observed tube occlusion at 18 months

    Time frame: 18 months±30 days following tympanostomy tube placement

    Percentage of ears with tubes occluded

  22. Provider-observed tube occlusion at 24 months

    Time frame: 24 months±30 days following tympanostomy tube placement

    Percentage of ears with tubes occluded

  23. Provider-observed tube occlusion at 30 months

    Time frame: 30 months±30 days following tympanostomy tube placement

    Percentage of ears with tubes occluded

  24. Provider-observed tube occlusion at 36 months

    Time frame: 36 months±30 days following tympanostomy tube placement

    Percentage of ears with tubes occluded

  25. Provider-observed tympanostomy tubes in place and patent at 12 months

    Time frame: 12 months±30 days following tympanostomy tube placement

    Percentage of ears with tympanostomy tubes in place and patent

  26. Provider-observed tympanostomy tubes in place and patent at 18 months

    Time frame: 18 months±30 days following tympanostomy tube placement

    Percentage of ears with tympanostomy tubes in place and patent

  27. Provider-observed tympanostomy tubes in place and patent at 24 months

    Time frame: 24 months±30 days following tympanostomy tube placement

    Percentage of ears with tympanostomy tubes in place and patent

  28. Provider-observed tympanostomy tubes in place and patent at 30 months

    Time frame: 30 months±30 days following tympanostomy tube placement

    Percentage of ears with tympanostomy tubes in place and patent

  29. Provider-observed tympanostomy tubes in place and patent at 36 months

    Time frame: 36 months±30 days following tympanostomy tube placement

    Percentage of ears with tympanostomy tubes in place and patent

  30. Ability to see through lumen and assess tube patency at 12 months

    Time frame: 12 months±30 days following tympanostomy tube placement

    Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency

  31. Ability to see through lumen and assess tube patency at 18 months

    Time frame: 18 months±30 days following tympanostomy tube placement

    Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency

  32. Ability to see through lumen and assess tube patency at 24 months

    Time frame: 24 months±30 days following tympanostomy tube placement

    Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency

  33. Ability to see through lumen and assess tube patency at 30 months

    Time frame: 30 months±30 days following tympanostomy tube placement

    Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency

  34. Ability to see through lumen and assess tube patency at 36 months

    Time frame: 36 months±30 days following tympanostomy tube placement

    Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency

  35. Ear-specific pure tone average

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Highest (worst) pure tone average of 500 Hz, 1000 Hz, 2000 Hz, and 3000 Hz in decibels

  36. Ear-specific speech-response threshold

    Time frame: 36 months±30 days following tympanostomy tube placement

    Highest (worst) speech-response threshold in decibels

  37. Ear-specific speech-awareness threshold

    Time frame: Within 36 months +/- 30 days following tympanostomy tube placement

    Highest (worst) speech-awareness threshold in decibels

Sponsors and collaborators

Lead sponsor

David Chi, MD

Other

Registry information

Official study title

Randomized Clinical Trial of Post-operative Outcomes Following Posterior Versus Anterior Tympanostomy Tube Placement

Important dates

Study start
2024
Primary completion
2028
Study completion
2028
First posted
Jan 5, 2024
Registry last updated
Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.